Skip to content
OpenCapital
Get started

BioMarin Pharmaceuticals BMRN EBIT

EBIT at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
——
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——
Cytokinetics logo
CytokineticsCYTK
——
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
——
Moderna logo
ModernaMRNA
——

Other financials

Income statement

See full
Revenue$766.2M+2.8%
Gross profit$571.2M-3.8%
Operating income$129.6M-42.1%
Net income$105.5M-43.2%
EPS (diluted)$0.54-43.2%

Balance sheet

See full
Cash & equivalents$3.1B+193%
Total debt$1.4B+138%
Total equity$6.2B+7.2%
Total assets$8.6B+20.2%

Cash flow

See full
Operating cash flow$220.7M+26.5%
CapEx$20.9M+24.8%
Free cash flow$199.7M+26.7%

Valuation

See full
Market cap$10.57B-19.4%
Enterprise value$8.93B-29.3%
P/E21.1×-22.7×
P/S3.3×-1.2×

Profitability

See full
Gross margin76.5%-2.9pp
Operating margin19.9%+7.2pp
Net margin16.8%+5.1pp
FCF margin23.7%+2.5pp

Returns & leverage

See full
Return on equity9.1%+2.8pp
Debt / equity0.2×+0.1×
Current ratio5.8×+0.3×

Where this comes from

Calculated from BioMarin Pharmaceuticals’s reported figures.

$129.6Moperating income+$141.2Mincome before tax+$15.0Minterest expense=$129.64M

The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioMarin Pharmaceuticals's EBIT?
BioMarin Pharmaceuticals (BMRN) reported EBIT of $129.64M in Q1 2026.
How has BioMarin Pharmaceuticals's EBIT changed year-over-year?
BioMarin Pharmaceuticals's EBIT decreased by 42.1% year-over-year, from $223.89M to $129.64M.
What is the long-term trend for BioMarin Pharmaceuticals's EBIT?
Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's EBIT has grown at a 53.5% compound annual growth rate (CAGR), from -$82.34M to $456.87M.
What does EBIT mean?
Profit before interest and taxes — the business's core earning power.
How do you interpret EBIT?
Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
How does EBIT compare across companies?
Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.